Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Patients Coinfected With HCV and HIV-1

Journal of Hepatology - Netherlands
doi 10.1016/s0168-8278(17)31947-5
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Elsevier BV

Related search

Ledipasvir and Sofosbuvir for HCV-infection in Patients Coinfected With HBV

Antiviral Therapy
Infectious DiseasesPharmacology
2016English

Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants During SOF/LDV Combination Therapy Against Genotype 1b Hepatitis C Virus (HCV)

Scientific Reports
Multidisciplinary
2017English

Effectiveness of 8- Or 12-Weeks of Ledipasvir and Sofosbuvir in Real-World Treatment-Naïve, Genotype 1 Hepatitis C Infected Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Efficacy of an 8-Week Course of Sofosbuvir and Ledipasvir for the Treatment of HCV Infection in Selected HIV-infected Patients

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2018English

Randomised Clinical Trial: Sofosbuvir and Ledipasvir in Patients With Transfusion-Dependent Thalassaemia and HCV Genotype 1 or 4 Infection

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

Hepatology
MedicineHepatology
2018English

All-Oral DAA Therapy Against HCV in HIV/HCV-coinfected Subjects in Real-World Practice: Madrid-CoRe Findings

Hepatology
MedicineHepatology
2018English

Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders

BMC Infectious Diseases
Infectious Diseases
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy